SRSF1 mediates cytokine-induced impaired imatinib sensitivity in chronic myeloid leukemia
出版年份 2020 全文链接
标题
SRSF1 mediates cytokine-induced impaired imatinib sensitivity in chronic myeloid leukemia
作者
关键词
-
出版物
LEUKEMIA
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-02-12
DOI
10.1038/s41375-020-0732-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment
- (2018) Elena Arrigoni et al. Stem Cells Translational Medicine
- Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
- (2017) Rebecca Mitchell et al. JNCI-Journal of the National Cancer Institute
- Targeting BCR-ABL-Independent TKI Resistance in Chronic Myeloid Leukemia by mTOR and Autophagy Inhibition
- (2017) Rebecca Mitchell et al. JNCI-Journal of the National Cancer Institute
- Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study
- (2016) Delphine Rea et al. BLOOD
- Secretion of IL-1β from imatinib-resistant chronic myeloid leukemia cells contributes toBCR-ABLmutation-independent imatinib resistance
- (2016) Cho-Rong Lee et al. FEBS LETTERS
- A role for FOXO1 in BCR–ABL1-independent tyrosine kinase inhibitor resistance in chronic myeloid leukemia
- (2016) M Wagle et al. LEUKEMIA
- Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer
- (2016) Liyan Jiang et al. PLoS Genetics
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal
- (2015) Frida Holm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition
- (2014) K. P. Ng et al. BLOOD
- BCR-ABL-Induced Deregulation of the IL-33/ST2 Pathway in CD34(+) Progenitors from Chronic Myeloid Leukemia Patients
- (2014) A. Levescot et al. CANCER RESEARCH
- Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer
- (2014) S. Das et al. MOLECULAR CANCER RESEARCH
- A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
- (2014) L. Ma et al. Science Translational Medicine
- European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
- (2013) M. Baccarani et al. BLOOD
- Identification of Alternative Splicing Events Regulated by the Oncogenic Factor SRSF1 in Lung Cancer
- (2013) F. J. de Miguel et al. CANCER RESEARCH
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
- (2012) Bin Zhang et al. CANCER CELL
- Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia
- (2012) Limin Zou et al. Journal of Hematology & Oncology
- Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors
- (2012) F U Wöhrle et al. LEUKEMIA
- The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
- (2012) Olga Anczuków et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SpliceAid-F: a database of human splicing factors and their RNA-binding sites
- (2012) Matteo Giulietti et al. NUCLEIC ACIDS RESEARCH
- Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway
- (2012) L Adesso et al. ONCOGENE
- Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
- (2012) Stephanie Gout et al. PLoS One
- BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance
- (2011) Hilmar Quentmeier et al. Journal of Hematology & Oncology
- Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors
- (2011) E Traer et al. LEUKEMIA
- SRSF1 Regulates the Alternative Splicing of Caspase 9 Via A Novel Intronic Splicing Enhancer Affecting the Chemotherapeutic Sensitivity of Non-Small Cell Lung Cancer Cells
- (2011) J. C. Shultz et al. MOLECULAR CANCER RESEARCH
- Sam68 regulates EMT through alternative splicing–activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene
- (2010) Cristina Valacca et al. JOURNAL OF CELL BIOLOGY
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
- (2008) Nadine N. Bewry et al. MOLECULAR CANCER THERAPEUTICS
- The splicing-factor oncoprotein SF2/ASF activates mTORC1
- (2008) R. Karni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now